These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 7921905)
1. Modified low density lipoproteins in the pathogenesis of atherosclerosis. Laurman W Int J Occup Med Environ Health; 1994; 7(1):65-76. PubMed ID: 7921905 [TBL] [Abstract][Full Text] [Related]
2. Glycation of low-density lipoprotein results in the time-dependent accumulation of cholesteryl esters and apolipoprotein B-100 protein in primary human monocyte-derived macrophages. Brown BE; Rashid I; van Reyk DM; Davies MJ FEBS J; 2007 Mar; 274(6):1530-41. PubMed ID: 17480204 [TBL] [Abstract][Full Text] [Related]
4. Interaction of oxidized low density lipoprotein with macrophages in atherosclerosis, and the antiatherogenicity of antioxidants. Aviram M Eur J Clin Chem Clin Biochem; 1996 Aug; 34(8):599-608. PubMed ID: 8877334 [TBL] [Abstract][Full Text] [Related]
5. [The role of modified low-density lipoproteins in physiology and pathology]. Caialo PP; Pliushch HI Fiziol Zh (1994); 2000; 46(2):124-36. PubMed ID: 10867871 [TBL] [Abstract][Full Text] [Related]
7. Oxidation of lipoproteins and atherosclerosis. Luc G; Fruchart JC Am J Clin Nutr; 1991 Jan; 53(1 Suppl):206S-209S. PubMed ID: 1985389 [TBL] [Abstract][Full Text] [Related]
8. Multifunctional roles of macrophages in the development and progression of atherosclerosis in humans and experimental animals. Takahashi K; Takeya M; Sakashita N Med Electron Microsc; 2002 Dec; 35(4):179-203. PubMed ID: 12658354 [TBL] [Abstract][Full Text] [Related]
9. Atherogenic, dense low-density lipoproteins. Pathophysiology and new therapeutic approaches. Chapman MJ; Guérin M; Bruckert E Eur Heart J; 1998 Feb; 19 Suppl A():A24-30. PubMed ID: 9519339 [TBL] [Abstract][Full Text] [Related]
10. The role of microscopy in understanding atherosclerotic lysosomal lipid metabolism. Jerome WG; Yancey PG Microsc Microanal; 2003 Feb; 9(1):54-67. PubMed ID: 12597787 [TBL] [Abstract][Full Text] [Related]
11. Oxidation decreases low density lipoprotein association with the subendothelium extracellular matrix. Savion N; Zavaro O; Kotev-Emeth S Biochem Biophys Res Commun; 1998 Apr; 245(2):497-501. PubMed ID: 9571183 [TBL] [Abstract][Full Text] [Related]
12. Oxidative modification of low density lipoprotein and its relation to atherosclerosis. Aviram M Isr J Med Sci; 1995 Apr; 31(4):241-9. PubMed ID: 7721566 [No Abstract] [Full Text] [Related]
13. [Oxidized lipoproteins and atherogenesis]. Jürgens G; Chen Q; Ledinski G; Kager G; Hammer A; Esterbauer H Acta Med Austriaca; 1993; 20(4):85-9. PubMed ID: 8237282 [TBL] [Abstract][Full Text] [Related]
14. Pomegranate juice flavonoids inhibit low-density lipoprotein oxidation and cardiovascular diseases: studies in atherosclerotic mice and in humans. Aviram M; Dornfeld L; Kaplan M; Coleman R; Gaitini D; Nitecki S; Hofman A; Rosenblat M; Volkova N; Presser D; Attias J; Hayek T; Fuhrman B Drugs Exp Clin Res; 2002; 28(2-3):49-62. PubMed ID: 12224378 [TBL] [Abstract][Full Text] [Related]
15. beta-Galactosidase-modified low density lipoprotein demonstrates increased susceptibility to lipid peroxidation and enhanced uptake by macrophages. Lavy A; Dankner G; Aviram M Isr J Med Sci; 1994 Dec; 30(12):905-7. PubMed ID: 8002274 [No Abstract] [Full Text] [Related]
16. [Interaction of native and modified low density lipoprotein with intimal cells in atherosclerotic lesion]. Nikoforov NG; Gratchev AN; Sobenin IA; Orekhov AN; Kzhyhskowska YG Patol Fiziol Eksp Ter; 2013; (1):109-17. PubMed ID: 23805724 [TBL] [Abstract][Full Text] [Related]